Masters Capital Mgmt »

Lucid Diagnostics shares owned by Masters Capital Mgmt

Quarter-by-quarter ownership of Lucid Diagnostics (LUCD) shares owned by Masters Capital Mgmt from 13F filings

Historical chart of Masters Capital Mgmt investment in Lucid Diagnostics

Tip: Access up to 7 years of quarterly data

All positions including Lucid Diagnostics held by Masters Capital Mgmt consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lucid Diagnostics by Masters Capital Mgmt

Quarter filed Position value Share count Share price at filing
2025-09-30 $4.0M 4.0M 1.01
2025-06-30 $3.1M 2.7M 1.15
2025-03-31 $4.1M 2.7M 1.49

More positions owned by Masters Capital Mgmt

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
International Business Machines Call Option (IBM)
Delta Air Lines Inc Del Com New (DAL)
Eastman Chemical Company (EMN)
Gilead Sciences Call Option (GILD)
United Parcel Service CL B (UPS)
Citigroup Com New Call Option (C)
Corning Incorporated Call Option (GLW)
Fluor Corporation (FLR)
Schlumberger Com Stk Call Option (SLB)
Intel Corporation Call Option (INTC)
Alcoa Call Option (AA)
General Motors Company Call Option (GM)
Archer Daniels Midland Company (ADM)
Bristol Myers Squibb (BMY)

View all positions for Masters Capital Mgmt

Top funds holding Lucid Diagnostics

Vanguard Group
Masters Capital Mgmt
BlackRock
Two Seas Capital
AWM Investment Company
Ghisallo Capital Management
Standard Life Aberdeen
Geode Capital Management
Alyeska Investment Group
Perkins Capital Management
State Street Corporation
Luminus Management
Wells Fargo & Company
Goldman Sachs Group
Northern Trust

View all funds holding Lucid Diagnostics